Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study

McPhail, Sean; Barclay, Matthew E; Johnson, Shane A; Swann, Ruth; Alvi, Riaz; Barisic, Andriana; Bucher, Oliver; Creighton, Nicola; Denny, Cheryl A; Dewar, Ron A; Donnelly, David W; Dowden, Jeff J; Downie, Laura; Finn, Norah; Gavin, Anna T; Habbous, Steven; Huws, Dyfed W; May, Leon; McClure, Carol A; Møller, Bjørn; Musto, Grace; Nilssen, Yngvar; Saint-Jacques, Nathalie; Sarker, Sabuj; Shack, Lorraine; Tian, Xiaoyi; Thomas, Robert J S; Thomson, Catherine S; Wang, Haiyan; Woods, Ryan R; You, Hui; Lyratzopoulos, Georgios; Altman, Alon D; Bennett, Damien; Butler, John; Cameron, David A; Crosby, Tom; Davies, Llion; Dixon, Elijah; Filsinger, Brooke; Forster, Katharina; Fung, Sharon; Gomez Navas, Elba; Guren, Marianne G; Han, Jihee; Hanna, Louise; Harrison, Samantha; Lawler, Mark; Little, Alana L; Mala, Tom; Merrett, Neil; Morrison, David S; Nelson, Gregg; Peacock, Stuart J; Ransom, David T; Ray-Coquard, Isabelle; Warlow, Janet L; Whitfield, Emma; Zalcberg, John R

doi:10.1016/s1470-2045(24)00031-7

Cited by 5 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, chemotherapy has broad applicability but is often accompanied by obvious side effects and drug resistance; phototherapy is a local treatment method with low side effects, but its penetration is limited; IMT can attack cancer cells by activating patients' immune systems, but it is only effective for a subset of patients. [36] Compared to a single treatment mode, combined therapy is usually more effective because multiple treatment methods can work synergistically and reduce toxic side effects. Zhang et al developed a biomimetic therapy system, termed as ARNGs@TMZ/ICG, that can be activated by NIR irradiation to facilitate deep penetration of drugs into glioma tissues (Figure 6a).…”

Section: Combined Therapymentioning

confidence: 99%

Biomimetic Nanocomposites for Glioma Imaging and Therapy

Chi,

Wang,

Liu

2024

Chemistry A European J

View full text Add to dashboard Cite

Glioma, the most common primary brain tumor, is highly invasive and grows rapidly. As such, the survival of glioma patients is relatively short, highlighting the vital importance of timely diagnosis and treatment of glioma. However, the blood brain barrier (BBB) and the non‐targeting delivery systems of contrast agents and drugs greatly hinder the effective glioma imaging and therapy. Fortunately, in recent years, investigators have constructed various biomimetic delivery platforms utilizing the exceptional advantages of biomimetic nanocomposites, such as immune evasion, homologous targeting ability, and BBB penetrating ability, to achieve efficient and precise delivery of substances to glioma sites for improved diagnosis and treatment. In this concept, we present the application of these biomimetic nanocomposites in fluorescence imaging (FI), magnetic resonance imaging (MRI), and multi‐modal imaging, as well as in chemotherapy, phototherapy, and combined therapy for glioma. Lastly, we provide our perspective on this research field.

show abstract

Section: Combined Therapymentioning

confidence: 99%